ExodusPoint Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-97,277
Closed -$1.76M 1702
2025
Q1
$1.76M Sell
97,277
-41,412
-30% -$742K 0.02% 736
2024
Q4
$2.41M Sell
138,689
-204,870
-60% -$3.93M 0.02% 653
2024
Q3
$6.63M Buy
343,559
+75,894
+28% +$1.4M 0.04% 317
2024
Q2
$4.39M Sell
267,665
-16,550
-6% -$257K 0.03% 449
2024
Q1
$4.33M Buy
+284,215
New +$4.46M 0.03% 437
2023
Q4
Sell
-68,923
Closed -$895K 1746
2023
Q3
$895K Sell
68,923
-36,164
-34% -$470K 0.01% 1002
2023
Q2
$1.34M Sell
105,087
-152,219
-59% -$1.91M 0.01% 986
2023
Q1
$2.9M Buy
257,306
+100,140
+64% +$1.22M 0.02% 737
2022
Q4
$2.08M Sell
157,166
-47,487
-23% -$624K 0.03% 626
2022
Q3
$2.38M Buy
204,653
+49,144
+32% +$674K 0.03% 717
2022
Q2
$2.29M Buy
155,509
+86,270
+125% +$1.41M 0.03% 726
2022
Q1
$1.34M Buy
69,239
+49,084
+244% +$877K 0.02% 975
2021
Q4
$348K Buy
+20,155
New +$343K ﹤0.01% 1595
2020
Q4
Sell
-22,318
Closed -$233K 2150
2020
Q3
$233K Buy
+22,318
New +$284K ﹤0.01% 1407

Other funds holding INVA

ExodusPoint Capital Management's INVA Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of Innoviva (INVA) in Q2 2025, closing a stake of 97,277 shares — an estimated $1.76M sold.

ExodusPoint Capital Management first reported a position in INVA in Q3 2020 and held it in 14 quarters. The position peaked at $6.63M in Q3 2024. 266 funds tracked by Wall St. Rank hold INVA as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining Innoviva position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 97,277 Innoviva shares in Q2 2025, an estimated $1.76M.
  • ExodusPoint Capital Management first reported a position in Innoviva in Q3 2020 and held it in 14 quarters.
  • ExodusPoint Capital Management's Innoviva position peaked at $6.63M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Innoviva as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.